Literature DB >> 1450621

HLA-DRB3 gene alleles in Caucasian patients with Graves' disease.

B O Boehm1, P Kühnl, B J Manfras, M Chen, J C Lee, G Holzberger, S Seidl, E Schifferdecker, P M Schumm-Draeger, K H Usadel.   

Abstract

Graves' disease (GD) is a human leukocyte antigen (HLA) linked organ-specific autoimmune disease. In German GD patients the disease is associated with HLA specificities of the HLA-DRw52 family (HLA-DR3, -DR5, and DR6; HLA-DRB3 positive HLA haplotypes). Recently, a strong association with a HLA-DRB3 restriction fragment length polymorphism gene has been described. To study HLA-DRB3 alleles and their association with the disease, a large cohort of controls (n = 3724) and GD patients (n = 304) was analyzed. HLA-DR allelic combinations revealed an increase in HLA-DR3/DR5 heterozygous patients (relative risk 2.9; P < 0.001). HLA-DRB3 alleles, as defined by DNA typing in HLA-DR matched groups revealed a significant increase in DRB3*0101 homozygosity (relative risk 17.5; P < 0.001) in HLA-DR3 homozygous patients. In GD patients with ophthalmopathy (grade II or higher, according to Werner) DRB3*0101/*0202 heterozygosity revealed an increased relative risk of 5.5 (P < 0.001). Non-HLA-DR3 homozygous, DRB3*0101/*0202 heterozygous patients were at the highest risk for endocrine ophthalmopathy (relative risk 10; P < 0.001). Our data, based on DNA typing methods of HLA-D genes, provide evidence that the susceptibility is strongly associated with HLA-DRB3 genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1450621     DOI: 10.1007/bf00180447

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  24 in total

Review 1.  Shared epitopes among HLA class II alleles: gene conversion, common ancestry and balancing selection.

Authors:  H A Erlich; U B Gyllensten
Journal:  Immunol Today       Date:  1991-11

2.  The impact of naturally occurring DR3 microvariants, DRw17 and DRw18, on T-cell allorecognition.

Authors:  A H Johnson; T F Tang; V Cowell; C K Hurley
Journal:  Hum Immunol       Date:  1991-09       Impact factor: 2.850

3.  Nomenclature for factors of the HLA system, 1990.

Authors:  J G Bodmer; S G Marsh; E D Albert; W F Bodmer; B Dupont; H A Erlich; B Mach; W R Mayr; P Parham; T Sasazuki
Journal:  Hum Immunol       Date:  1991-07       Impact factor: 2.850

4.  Factors influencing the outcome of thyrostatic drug therapy in Graves' disease.

Authors:  B Winsa; A Dahlberg; R Jansson; H Agren; F A Karlsson
Journal:  Acta Endocrinol (Copenh)       Date:  1990-06

5.  Implication of the HLA-DRB3 gene in Graves' disease: predominance of allele Dw24.

Authors:  G Semana; H Allanic; F Quillivic; M T Vallejo; J P Simon; B Genetet; R Fauchet
Journal:  Hum Immunol       Date:  1990-10       Impact factor: 2.850

6.  A molecular basis for MHC class II--associated autoimmunity.

Authors:  J A Todd; H Acha-Orbea; J I Bell; N Chao; Z Fronek; C O Jacob; M McDermott; A A Sinha; L Timmerman; L Steinman
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

7.  DNA typing for class II HLA antigens with allele-specific or group-specific amplification. II. Typing for alleles of the DRw52-associated group.

Authors:  M Fernandez-Vina; W Shumway; P Stastny
Journal:  Hum Immunol       Date:  1990-05       Impact factor: 2.850

8.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

9.  Restriction fragment length polymorphisms and an HLA-DRw52-associated split.

Authors:  M Chatila; L Luyrink; J McEleney; T Spies; J L Strominger; D N Glass
Journal:  Hum Immunol       Date:  1988-02       Impact factor: 2.850

10.  The genetics of Graves' disease: HLA and disease susceptibility.

Authors:  V Stenszky; L Kozma; C Balázs; S Rochlitz; J C Bear; N R Farid
Journal:  J Clin Endocrinol Metab       Date:  1985-10       Impact factor: 5.958

View more
  4 in total

Review 1.  Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond.

Authors:  M J Simmonds; S C L Gough
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

2.  Immunogenetic mechanisms leading to thyroid autoimmunity: recent advances in identifying susceptibility genes and regions.

Authors:  Oliver J Brand; Stephen C L Gough
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

3.  Graves' ophthalmopathy: a review of immunogenetics.

Authors:  Omid Khalilzadeh; Sina Noshad; Armin Rashidi; Aliakbar Amirzargar
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

4.  HLA DRB1*03 as a possible common etiology of schizophrenia, Graves' disease, and type 2 diabetes.

Authors:  Aicha Sayeh; Cheker Ben Cheikh; Ali Mardessi; Meriem Mrad; Brahim Nsiri; Abdelaziz Oumaya; Najiba Fekih-Mrissa
Journal:  Ann Gen Psychiatry       Date:  2017-02-02       Impact factor: 3.455

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.